A Thomas Look Selected Research

Protein-Tyrosine Kinases (Tyrosine Kinase)

3/2024	STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.
5/2013	TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.
11/2005	The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Thomas Look Research Topics

Disease

57	Neoplasms (Cancer) 03/2023 - 08/2003
35	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2022 - 07/2003
28	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 03/2004
25	Neuroblastoma 12/2023 - 12/2005
20	Leukemia 11/2022 - 10/2002
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 07/2004
5	Carcinogenesis 03/2024 - 06/2005
5	Sarcoma (Soft Tissue Sarcoma) 11/2022 - 09/2011
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2024 - 03/2009
4	Ganglioneuroma 01/2021 - 10/2009
4	Genetic Translocation (Chromosomal Translocation) 01/2019 - 01/2005
3	Adenocarcinoma 01/2020 - 10/2014
3	Lymphoma (Lymphomas) 01/2019 - 06/2007
3	Neurofibrosarcoma (MPNST) 01/2019 - 12/2010
3	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2012 - 05/2008
3	Inflammation (Inflammations) 08/2009 - 12/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 03/2023 - 01/2023
2	Melanoma (Melanoma, Malignant) 01/2021 - 02/2005
2	Glioma (Gliomas) 01/2019 - 12/2010
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2014 - 09/2012
2	Chromosome 5q Deletion Syndrome 11/2014 - 11/2012
2	T-Cell Leukemia (Leukemia, T Cell) 01/2014 - 09/2004
2	Ganglioneuroblastoma 03/2013 - 10/2009
2	Carcinoma (Carcinomatosis) 10/2012 - 03/2008
2	Glioblastoma (Glioblastoma Multiforme) 12/2010 - 03/2009
2	Wounds and Injuries (Trauma) 06/2009 - 08/2008
2	Acute Promyelocytic Leukemia 06/2007 - 04/2004
1	Neoplasm Metastasis (Metastasis) 01/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021
1	alpha-Thalassemia 01/2019
1	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 01/2019

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 11/2022 - 08/2003
17	Transcription Factors (Transcription Factor)IBA 12/2023 - 03/2004
14	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2004
10	Phosphotransferases (Kinase)IBA 01/2020 - 11/2005
7	Adrenergic Agents (Adrenergic Drugs)IBA 12/2023 - 12/2019
6	EnzymesIBA 01/2023 - 02/2007
5	Biomarkers (Surrogate Marker)IBA 11/2022 - 11/2005
5	Gamma Secretase Inhibitors and ModulatorsIBA 03/2010 - 02/2007
4	ChromatinIBA 12/2023 - 01/2018
4	Sirolimus (Rapamycin)FDA Link 01/2021 - 09/2012
4	N-Myc Proto-Oncogene ProteinIBA 01/2021 - 03/2013
4	Anaplastic Lymphoma KinaseIBA 01/2021 - 03/2009
4	RNA (Ribonucleic Acid)IBA 01/2019 - 04/2005
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 08/2008
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2016 - 07/2004
4	Messenger RNA (mRNA)IBA 08/2011 - 03/2004
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2024 - 11/2005
3	Histones (Histone)IBA 10/2021 - 01/2007
3	MTOR InhibitorsIBA 01/2021 - 10/2020
3	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 11/2005
3	Small Interfering RNA (siRNA)IBA 01/2018 - 10/2008
3	Ribosomal Proteins (Ribosomal Protein)IBA 11/2014 - 09/2012
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2014 - 05/2006
3	Neurofibromin 1 (Neurofibromin)IBA 11/2012 - 12/2009
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 04/2009 - 01/2006
3	Notch ReceptorsIBA 04/2009 - 06/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022 - 12/2005
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2021 - 06/2007
2	RetinoidsIBA 10/2021 - 01/2016
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 02/2005
2	Drug CombinationsIBA 01/2021 - 01/2019
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2020 - 12/2016
2	GenieIBA 01/2020 - 01/2019
2	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2011
2	Basic-Leucine Zipper Transcription FactorsIBA 01/2018 - 06/2005
2	ElementsIBA 01/2018 - 12/2015
2	Oncogene Proteins (Oncogene Protein)IBA 12/2016 - 10/2002
2	Interleukin-7 (Interleukin 7)IBA 01/2015 - 03/2004
2	Leucine (L-Leucine)FDA Link 11/2014 - 09/2012
2	T-Cell Acute Lymphocytic Leukemia Protein 1IBA 07/2013 - 08/2012
2	LigandsIBA 07/2012 - 03/2009
2	NucleophosminIBA 04/2010 - 03/2009
2	CytokinesIBA 01/2010 - 04/2004
2	alpha Catenin (alpha E-Catenin)IBA 01/2007 - 01/2005
1	5-hydroxymethylcytosineIBA 01/2023
1	5-Methylcytosine (5 Methylcytosine)IBA 01/2023
1	DioxygenasesIBA 01/2023
1	Topoisomerase II InhibitorsIBA 11/2022
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 11/2022
1	Asparaginase (Elspar)FDA Link 11/2022
1	hydrogen sulfite (bisulfite)IBA 11/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2021
1	temsirolimus FDA Link 01/2021
1	Everolimus FDA Link 01/2021
1	NAD (NADH)IBA 01/2021
1	dihydrolipoamideIBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	IACS-010759IBA 01/2021
1	HoloenzymesIBA 01/2020
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2020
1	Doublecortin-Like KinasesIBA 01/2020
1	nelarabine (506U78)FDA Link 10/2019
1	S63845IBA 01/2019
1	venetoclaxIBA 01/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019

Therapy/Procedure

34	Therapeutics 01/2023 - 07/2003
10	Drug Therapy (Chemotherapy) 11/2022 - 12/2004
2	Transplantation 01/2012 - 09/2004
1	Breast Implants (Breast Implant) 01/2021